JPH11507050A - 前立腺病の処置および予防 - Google Patents

前立腺病の処置および予防

Info

Publication number
JPH11507050A
JPH11507050A JP9501341A JP50134197A JPH11507050A JP H11507050 A JPH11507050 A JP H11507050A JP 9501341 A JP9501341 A JP 9501341A JP 50134197 A JP50134197 A JP 50134197A JP H11507050 A JPH11507050 A JP H11507050A
Authority
JP
Japan
Prior art keywords
shbg
compound
diol
estradiol
steroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9501341A
Other languages
English (en)
Japanese (ja)
Inventor
スミス，ロイ・ジイ
ローズナー，ウイリアム
ナカーラ，エイテイフ・エム
Original Assignee
メルク エンド カンパニー インコーポレーテッド
セント・ルークズ／ルーズベルト・ホスピタル・センター
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メルク エンド カンパニー インコーポレーテッド, セント・ルークズ／ルーズベルト・ホスピタル・センター filed Critical メルク エンド カンパニー インコーポレーテッド
Publication of JPH11507050A publication Critical patent/JPH11507050A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP9501341A 1995-06-07 1996-06-05 前立腺病の処置および予防 Pending JPH11507050A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48463395A 1995-06-07 1995-06-07
US08/484,633 1995-06-07
PCT/US1996/008873 WO1996040150A1 (en) 1995-06-07 1996-06-05 Treatment and prevention of prostatic disease

Publications (1)

Publication Number Publication Date
JPH11507050A true JPH11507050A (ja) 1999-06-22

Family

ID=23924956

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9501341A Pending JPH11507050A (ja) 1995-06-07 1996-06-05 前立腺病の処置および予防

Country Status (5)

Country Link
EP (1) EP0833641A4 (de)
JP (1) JPH11507050A (de)
AU (1) AU5984196A (de)
CA (1) CA2222625A1 (de)
WO (1) WO1996040150A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004002321A (ja) * 2002-03-11 2004-01-08 Takeda Chem Ind Ltd 性ホルモン依存性疾患治療剤
US8518890B2 (en) 2002-03-11 2013-08-27 Takeda Pharmaceutical Company Limited Remedies for sex hormone dependent disease

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004071533A1 (ja) * 2003-02-14 2004-08-26 Takeda Pharmaceutical Company Limited 局所投与用製剤
WO2006081658A1 (en) * 2005-02-01 2006-08-10 The University Of British Columbia In silico screening for shbg binding ligands via pharmacophore models
WO2007031833A2 (en) * 2005-09-15 2007-03-22 Council Of Scientific And Industrial Research Novel series of imidazolyl substituted steroidal and indan-1-one derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2817157A1 (de) * 1978-04-17 1979-10-25 Schering Ag Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie
IN171596B (de) * 1989-06-27 1992-11-21 Cohen Michael
US5407944A (en) * 1993-02-19 1995-04-18 Goldman; Boris E. Compositions and methods for promoting hair growth
US5504074A (en) * 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004002321A (ja) * 2002-03-11 2004-01-08 Takeda Chem Ind Ltd 性ホルモン依存性疾患治療剤
US8518890B2 (en) 2002-03-11 2013-08-27 Takeda Pharmaceutical Company Limited Remedies for sex hormone dependent disease

Also Published As

Publication number Publication date
EP0833641A1 (de) 1998-04-08
CA2222625A1 (en) 1996-12-19
WO1996040150A1 (en) 1996-12-19
EP0833641A4 (de) 2000-04-05
AU5984196A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
Lai et al. The role of androgen and androgen receptor in skin-related disorders
TWI477276B (zh) 抗黃體素給藥方案
TWI263499B (en) Pharmaceutical compositions and uses for androst-5-ene-3beta,17beta-diol
JP5363309B2 (ja) ４，１７β−ジヒドロキシアンドロスト−４−エン−３−オンの新規な使用
JP2000515523A (ja) 創傷および線維性障害の治療における性ステロイド機能モジュレーターの使用
JP2001510471A (ja) アンドロゲン合成インヒビター
JP2013060475A (ja) 閉経を処置するためのｄｈｅａ組成物
ES2643318T3 (es) Composiciones y métodos para suprimir la proliferación endometrial
JP2011518883A (ja) 乳癌を治療するための組成物および方法
Flores et al. Steroid 5α-reductase inhibitors
Hild et al. CDB-2914: anti-progestational/anti-glucocorticoid profile and post-coital anti-fertility activity in rats and rabbits
Bernardi et al. Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels
CN101854979B (zh) 用于治疗性应用的c-19甾族化合物
Al-Azzawi Endocrinological aspects of the menopause
Faloia et al. Effect of finasteride in idiopathic hirsutism
JPH11507050A (ja) 前立腺病の処置および予防
Tucci et al. Endocrine studies in an arrhenoblastoma responsive to dexamethasone, ACTH and human chorionic gonadotropin
EP2632471B1 (de) Trimegeston (tmg) zur behandlung von frühgeburten
Rasmusson et al. Therapeutic control of androgen action
Bevan et al. Endocrine effects of danazol in the treatment of endometriosis
Anastassakis Progestins
TW200927137A (en) Compositions and methods for treating dysfunctional uterine bleeding
EP1303270B1 (de) Methoden zur behandlung des kryptorchysmus
Oettel et al. What is past is prologue: estrogen/progestin replacement tomorrow
TW200950788A (en) Compositions and methods for male contraception